References

The physiology of the lymphatic system

10.1016/s0169-409x(01)00150-8 · 2001 · External reference

Lymphedema following axillary lymph node dissection for breast cancer

10.1016/j.suronc.2006.11.003 · 2006 · External reference

Lymphedema—the seemingly forgotten complication

10.1016/0885-3924(94)90105-8 · 1994 · External reference

Lymphedema

10.1016/s0002-9343(00)00727-0 · 2001 · External reference

Pretreatment lymphedema education and identified educational resources in breast cancer patients

10.1016/j.pec.2005.02.009 · 2006 · External reference

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial

10.1093/jnci/djj158 · 2006 · External reference

The problem of post-breast cancer lymphedema: impact and measurement issues

10.1081/cnv-48707 · 2005 · External reference

Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma

10.1016/j.ejso.2006.05.003 · 2006 · External reference

HGF and MET mutations in primary and secondary lymphedema

10.1089/lrb.2008.1524 · 2008 · External reference

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

10.1038/75997 · 2000 · External reference

Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia

10.1086/375614 · 2003 · External reference

Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome

10.1086/316915 · 2000 · External reference

Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24

10.1136/jmg.39.7.478 · 2002 · External reference

FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedemadistichiasis syndrome

10.1093/hmg/ddg123 · 2003 · External reference

The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis

10.1101/gad.907301 · 2001 · External reference

New horizons for imaging lymphatic function

10.1196/annals.1413.002 · 2008 · External reference

Lymphedema: classification, diagnosis and therapy

10.1177/1358836x9800300209 · 1998 · External reference

New approaches to lymphatic imaging

10.1089/lrb.2009.0021 · 2009 · External reference

Near-infrared fluorescence imaging in humans with indocyanine green: a review and update

2010 · External reference

Lymphatic imaging in humans with near-infrared fluorescence

10.1016/j.copbio.2009.01.009 · 2009 · External reference

Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography

10.1016/j.ejvs.2008.04.013 · 2008 · External reference

Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema

10.1016/j.jvs.2007.01.023 · 2007 · External reference

Impaired lymphatic function recovered after great saphenous vein stripping in patients with varicose vein: venodynamic and lymphodynamic results

10.1016/j.jvs.2009.06.003 · 2009 · External reference

Imaging of lymph flow in breast cancer patients after microdose administration of a near infrared fluorophore: feasibility study

10.1148/radiol.2463070962 · 2008 · External reference

Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography

10.1016/s0039-6257(00)00123-5 · 2000 · External reference

Unresolved reference

2008 · External reference

A model for gene therapy of human hereditary lymphedema

10.1073/pnas.221449198 · 2001 · External reference

Distribution, propagation, and coordination of contractile activity in lymphatics

10.1152/ajpheart.1993.264.4.h1283 · 1993 · External reference

Unresolved reference

2006 · External reference

Functional lymphatic imaging in tumor-bearing mice

10.1016/j.jim.2010.06.016 · 2010 · External reference